Innovation and excellence in science and health

2) Collaborate with clinicians

2) Collaborate with clinicians

Benefit from a “market-pull” environment

When it comes to designing and developing medical products, it makes sense to start with the unmet needs of your target market. A facility on the Campus will place your business at the heart of a community of over 7000 healthcare professionals responsible for treating more than half a million patients a year.


Healthcare Professionals

Clinical services on the Biomedical Campus are delivered by Cambridge University Hospitals – Addenbrooke’s Hospital and the Rosie Hospital – with some additional services provided by Cambridgeshire and Peterborough Mental Health Trust.  Papworth Hospital is due to relocate to the Campus in 2016.

Professor Stephen O

We are excited about the prospect of having aspirational companies as our neighbours here. It’s a fantastic opportunity for us to collaborate with them and help ensure their products address the unmet medical needs of our patients.

Professor Stephen O'Rahilly

Professor of Clinical Biochemistry & Medicine, University of Cambridge

A location on the Campus will enable you to:

  • Establish relationships with key opinion leaders at an early stage in your product development life cycle
  • Ensure your products are fit-for-purpose by collaborating with NHS and research clinicians from Cambridge University Hospitals NHS Foundation Trust, Papworth Hospital and the University of Cambridge School of Clinical Medicine
  • Gain invaluable insights into the bottlenecks, challenges and unmet needs of consultants, doctors and nurses who treat half a million patients a year
  • Engage NHS business managers to help you understand the route for adoption of your products into the NHS as well as any potential pricing and reimbursement issues


New medical products are most successful when they are designed to work across the clinical care system not just in individual clinics. If companies have innovative new ideas, we welcome the opportunity to help them adapt their systems at an early stage in their thinking so that the chance of success and adoption is maximised.
Dr Basil Matta, MA FRCA Divisional Director, Emergency and Perioperative Care Cambridge University Hospitals Trust


Pfizer-Cambridge Centre for Cardiovascular Genomics

Established in 2012, this centre is underpinned by support from Pfizer, BHF, and the MRC, with a contribution from the NIHR Cambridge Biomedical Research Centre. The objective of the Centre is to identify and validate potential therapeutic targets for cardiovascular disease through the focussed application of population science approaches.